statistiche ricercatore

TANDA, MARIA LAURA PIERA

Distribuzione geografica

Continente	#
NA - Nord America	15.519
EU - Europa	7.166
AS - Asia	5.806
SA - Sud America	708
Continente sconosciuto - Info sul continente non disponibili	331
AF - Africa	130
OC - Oceania	16
AN - Antartide	1
Totale	29.677

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	15.250
IT - Italia	3.382
SG - Singapore	1.836
CN - Cina	1.376
UA - Ucraina	869
VN - Vietnam	781
HK - Hong Kong	627
SE - Svezia	622
BR - Brasile	556
DE - Germania	476
TR - Turchia	452
FI - Finlandia	330
GB - Regno Unito	323
IE - Irlanda	323
FR - Francia	276
BD - Bangladesh	271
RU - Federazione Russa	195
CA - Canada	135
IN - India	130
JP - Giappone	98
MX - Messico	87
PL - Polonia	63
AR - Argentina	52
NL - Olanda	49
NG - Nigeria	46
AT - Austria	43
CZ - Repubblica Ceca	38
ES - Italia	35
IQ - Iraq	33
ZA - Sudafrica	33
MY - Malesia	28
EC - Ecuador	24
BE - Belgio	23
CL - Cile	23
CH - Svizzera	21
LT - Lituania	20
ID - Indonesia	19
PK - Pakistan	19
AE - Emirati Arabi Uniti	16
IL - Israele	15
EU - Europa	14
UZ - Uzbekistan	14
RO - Romania	13
CO - Colombia	12
HN - Honduras	11
NP - Nepal	11
PH - Filippine	11
VE - Venezuela	11
JM - Giamaica	9
KR - Corea	9
MA - Marocco	9
MD - Moldavia	9
PE - Perù	9
PY - Paraguay	9
SA - Arabia Saudita	9
TH - Thailandia	9
AU - Australia	8
JO - Giordania	8
KE - Kenya	8
NZ - Nuova Zelanda	8
MT - Malta	7
TN - Tunisia	7
CR - Costa Rica	6
DZ - Algeria	6
EG - Egitto	6
BG - Bulgaria	5
GT - Guatemala	5
HU - Ungheria	5
KG - Kirghizistan	5
PT - Portogallo	5
UY - Uruguay	5
AL - Albania	4
BO - Bolivia	4
BY - Bielorussia	4
MK - Macedonia	4
TW - Taiwan	4
AZ - Azerbaigian	3
BA - Bosnia-Erzegovina	3
CI - Costa d'Avorio	3
DK - Danimarca	3
DO - Repubblica Dominicana	3
HR - Croazia	3
IR - Iran	3
KZ - Kazakistan	3
NI - Nicaragua	3
RS - Serbia	3
SN - Senegal	3
SR - Suriname	3
SV - El Salvador	3
BH - Bahrain	2
CG - Congo	2
EE - Estonia	2
ET - Etiopia	2
GR - Grecia	2
KW - Kuwait	2
SK - Slovacchia (Repubblica Slovacca)	2
TT - Trinidad e Tobago	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AO - Angola	1
Totale	29.336

Salva come PNG Salva come JPEG

Città	#
Milan	2.121
Fairfield	1.411
Ashburn	1.395
Dallas	1.274
San Jose	1.177
Singapore	1.058
Woodbridge	831
Chandler	737
Jacksonville	685
Houston	679
Hong Kong	610
Seattle	572
Wilmington	527
Cambridge	451
Council Bluffs	392
Dearborn	367
Ann Arbor	354
Beijing	331
Nyköping	322
Dublin	306
Princeton	303
The Dalles	234
Izmir	216
Boardman	213
Rome	203
Los Angeles	198
New York	194
Chicago	190
Lauterbourg	184
Dong Ket	164
Ho Chi Minh City	137
Helsinki	132
Santa Clara	126
Hanoi	114
Como	105
San Diego	103
London	96
Orem	81
Tokyo	81
San Mateo	78
São Paulo	75
Munich	74
Guangzhou	66
Washington	61
Ogden	60
Warsaw	54
Frankfurt am Main	53
Shanghai	50
Buffalo	49
Phoenix	48
Redmond	48
Mexico City	47
Chennai	46
Montreal	46
Abuja	45
Denver	44
San Francisco	43
Hefei	41
Toronto	38
Atlanta	37
Varese	37
Brooklyn	34
Brno	33
Kunming	33
Manchester	32
Haiphong	27
Düsseldorf	26
Vienna	26
Johannesburg	25
Nuremberg	25
Poplar	25
Stockholm	23
Turku	23
Amsterdam	22
Brussels	22
Salt Lake City	22
Nanjing	21
Norwalk	21
Boston	20
Naples	20
Paris	20
Shenzhen	20
Cavaria con Premezzo	19
Tampa	19
Tianjin	19
Da Nang	18
Hangzhou	18
Belo Horizonte	17
Berlin	17
Jinan	17
Las Vegas	17
North Bergen	17
Turin	17
Kuala Lumpur	16
Charlotte	15
Istanbul	15
Elk Grove Village	14
Mumbai	14
Zhengzhou	14
Ankara	13
Totale	20.630

Salva come PNG Salva come JPEG

Nome	#
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy	342
Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy	277
Graves' ophthalmopathy	274
Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma	264
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study	264
Epidemiology, natural history, risk factors, and prevention of graves’ orbitopathy	260
Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?	258
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study	257
Simultaneous medullary and papillary thyroid cancer: two case reports.	256
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management	253
Masked hypertension in newly diagnosed hypothyroidism: a pilot study	251
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?	243
Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature	234
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study	233
Breast cancer and thyroid diseases: analysis of 867 consecutive cases	233
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study	229
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial	227
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European Endocrinologists	226
Multidisciplinary Management of Intrathoracic Goiter: A Case Report	224
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	223
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?	220
Amiodarone-unduced thyrotoxicosis. A review	220
Pituitary apoplexy during pregnancy: A rare, but dangerous headache	218
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity	217
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?	215
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study	215
Effects of Melissa officinalis Phytosome on Sleep Quality: Results of a Prospective, Double-Blind, Placebo-Controlled, and Cross-Over Study	214
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe	213
Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces	211
Can a patient-tailored treatment approach for Graves' disease reduce mortality?	211
Continuous monitoring of the recurrent laryngeal nerve in thyroid surgery: a critical appraisal	210
Minimally invasive follicular thyroid cancer (MIFTC) - A consensus report of the European Society of Endocrine Surgeons (ESES)	210
Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs	209
Nutrizione iodica e ipertiroidismo: quello che c’è da sapere	208
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association	208
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study	206
Thyroid cancer with tracheal invasion: A pathological estimation	205
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose?	205
Physical performance in newly diagnosed hypothyroidism: a pilot study	204
Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study	204
Case report: multiple electrolyte disturbance with severe neurological manifestations induced by chronic use of PPIs	201
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)	201
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	201
Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction	199
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal	197
Novel treatment modalities for Graves' orbitopathy	196
Skeletal health in patients with differentiated thyroid carcinoma	196
An update on medical management of Graves' ophthalmopathy	194
Medullary thyroid carcinoma: surgical treatment advances	193
Iodine supplementation in women of reproductive age: a survey of clinical practice among Italian gynecologists and midwives	190
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy	189
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group	189
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.	185
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center	184
Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding?	184
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels:studies in vivo by color flow Doppler sonography	181
Orbital radiotherapy for Graves' ophthalmopathy	181
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study	179
Shortening Hospital Stay for Thyroid Surgery.	177
Medullary thyroid carcinoma: surgical treatment advances	176
Analisi dei costi	174
Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study	173
An update on the pharmacological management of hyperthyroidism due to Graves' disease	172
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy	171
Relationship between management of hyperthyroidism and course of the ophthalmopathy	171
Pituitary in black—hypopituitarism secondary to hemosiderosis	170
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	170
Amyloid goiter	169
Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature	168
Radioiodine and thyroid-associated ophthalmopathy	167
Amiodarone and the thyroid	167
Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications	166
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement.	165
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	165
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations	164
Treating Graves' orbitopathy: where are we?	164
Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives.	163
Orbital radiotherapy for Graves' ophthalmopathy	161
Management of thyroid eye disease	161
Thyroid autoimmunity and environment	161
Cigarette smoking and treatment outcomes in Graves' ophthalmopathy	160
Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions	160
Efficacy and safety of orbital radiotherapy for Graves' orbitopathy	159
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?	156
Recent developments in the follow-up, prevention and management of complications in thyroid surgery	156
Cigarette smoking and the thyroid	155
Novel approaches to the management of Graves' ophthalmopathy	155
When primary hyperparathyroidism comes as good news	154
Orbital decompression in Graves' ophthalmopathy by medial and lateral wall removal	153
Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression	153
La prevenzione dell'oftalmopatia basedowiana	152
Smoking and the Thyroid	152
Orbital radiotherapy for Graves' ophthalmopathy	151
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying	151
Position statement of the Microbiota International Clinical Society	149
Prevalence and natural history of Graves' orbitopathy in the XXI century	148
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	148
Novel immunomodulating agents for Graves orbitopathy	147
Image-guided thyroid nodule ablation: technical notes and critical appraisal	147
Solitary intrathyroidal metastasis of renal clear cell carcinoma in a toxic substernal multinodular goiter.	147
Totale	19.439

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	123.595
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	123.595

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.653	0	169	89	71	111	139	117	88	246	291	128	204
2022/2023	2.201	272	139	170	230	158	486	16	265	264	82	52	67
2023/2024	3.560	531	536	544	653	643	333	19	41	95	46	17	102
2024/2025	2.905	14	26	435	126	100	145	135	210	306	230	366	812
2025/2026	9.719	624	737	998	1.184	800	484	1.791	581	859	637	566	458
2026/2027	1.077	581	496	0	0	0	0	0	0	0	0	0	0
Totale													29.677